Stock listing

Kala Bio, Inc.

Selected listing: 27F · MUN · EUR · DE

Kala Bio, Inc. (Munich:27F), Health Technology. Latest release Sep 29, 2026: KALA Bio Signs Non-Binding LOI to Acquire Nationwide Telehealth Platform…

27F:MUNEURDEUpdated September 25, 2026

Ticker: Munich:27F
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Munich
Currency: EUR

Latest news from Kala Bio, Inc.

KALA Bio Signs Non-Binding LOI to Acquire Nationwide Telehealth Platform with Approximately $48 Million in Sales Since Inception

September 29, 2026

KALA BIO Adds Healthcare Operator Yenvy Truong to Advisory Team

September 17, 2026

Kala Bio and Virotek Finalize Definitive Agreement Establishing Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program

September 3, 2026

Kala Bio and Virotek Announce Letter of Intent to Establish an Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program

September 1, 2026

Kailera Therapeutics Appoints Kathleen Tregoning as Chief Corporate Affairs Officer

June 29, 2026

All Kala Bio, Inc. news →

Events

Replays

KALA BIO, Inc. (KALA) Q2 2022 Earnings Call
Thu, Aug 11, 2022 · 08:00 AM ET
Watch
KALA BIO, Inc. (KALA) Q1 2022 Earnings Call
Mon, May 16, 2022 · 08:00 AM ET
Watch
KALA BIO, Inc. (KALA) Q4 2021 Earnings Call
Tue, Mar 29, 2022 · 08:00 AM ET
Watch

Research Kala Bio, Inc.

Kala Bio, Inc. company profile

View the public company page for Kala Bio, Inc. on 6ix.

Kala Bio, Inc. news

Read company news and market updates connected to Kala Bio, Inc..

Kala Bio, Inc. investor events

Find investor webinars, events, and replay context for Kala Bio, Inc..